معرفی
Dr. Michael Drozd is an Academic Clinical Lecturer in the School of Medicine at the University of Leeds, part of the Faculty of Medicine and Health. He is affiliated with the Leeds Institute of Cardiovascular and Metabolic Medicine, where he conducts translational research in cardiology with a focus on cardiometabolic diseases and infection. His work bridges clinical practice and scientific investigation, particularly in understanding how metabolic conditions like diabetes influence cardiovascular and infectious disease outcomes.
- Position: Academic Clinical Lecturer
- Institution: University of Leeds
- School: School of Medicine
- Research Institute: Leeds Institute of Cardiovascular and Metabolic Medicine
- Email: M.Drozd@leeds.ac.uk
Dr. Drozd holds a BSc, MBChB (with honors), and PhD. He is a member of the Royal College of Physicians (MRCP) and the European Society of Cardiology (FESC), reflecting his clinical and academic credentials.
His research interests center on cardiometabolic disease and infection, with a strong emphasis on translational approaches. Key areas include:
- Mechanisms linking diabetes, obesity, and cardiovascular disease
- Infection-related mortality in metabolic disorders
- Endothelial signaling in vascular dysfunction
- Biomarker discovery in heart failure
- Hypoxia and innate immune training
- Inflammation as a driver of cardiovascular risk
His recent publications, spanning from 2017 to 2025, demonstrate a consistent output in high-impact journals such as Diabetes Care, Cardiovascular Research, The Lancet, and J Infect. These works often utilize large cohort data (e.g., UK Biobank) and molecular techniques to explore causal relationships and novel pathways. A recurring theme is the intersection of metabolic health, immune response, and cardiovascular outcomes.
Dr. Drozd is actively involved in medical education, supervising MBChB students and academic foundation doctors, and delivering cardiovascular teaching across multiple years of the medical curriculum. He is also passionate about widening participation in medicine, contributing to equity in medical education.
His scientific contributions include:
- Investigating plasma MERTK as a causal biomarker for infection mortality
- Identifying novel transcriptomic biomarkers (Erbb3, Hspa2) in diabetic heart failure
- Elucidating IGF-1 signaling in endothelial barrier function and atherogenesis
- Mapping comorbidity trajectories in heart failure
- Exploring mentorship challenges in cardiology training
Dr. Drozd collaborates extensively with leading researchers such as Professor Mark T. Kearney, Dr. Ryan M. Cubbon, and Professor Stephen B. Wheatcroft. He is not listed as retired, deceased, or former staff, and there is no indication of part-time status. His ongoing research and teaching activities confirm his active role in academic medicine.
